News

The SLIM is a high shear mixer system which uses rotor/stator assembly to generate a powerful vacuum to draw solids into the mix chamber. The liquid stream enters

The new patent covers the methods of using vosaroxin at clinically relevant dose ranges and schedules for leukemia treatment. Sunesis is now recruiting patients for Valor Phase 3

Incyte has also received priority review status for ruxolitinib NDA, which the FDA aims to complete within six months. The NDA submission is supported by the results from

NPS Pharma has posted net loss of $6.13m, compared to $6.3m for the same period in the prior year. The company’s operating income was $4.04m for the second

Kadrige is engaged in forming a team of consultants, sales professionals, project managers and information technology engineers for marketing range of services with a plan to enable biopharma

Following the termination, the Nordic region’s distribution rights will again go back to Oasmia Pharma. Oasmia Pharma has developed a water soluble formulation of Paclitaxel with the retinoid

The tie up allows the US based company to carry forward the clinical development, manufacturing and commercialization of VR315 product. Vectura will provide support for the US development

The 505(b)(2) filing of NDA was supported by the results from a Phase 3 Freedom-301 clinical trial and an open-label, safety extension which was intended to investigate overall

Cephalon‘s net income was $115.19m, compared to $92.39m for the same period in the prior year. The company’s income from operations was $148.39m for the second quarter ended